Latest Conference Articles

AAO official voices optimism for future of health care with incoming Biden admin

AAO official voices optimism for future of health care with incoming Biden admin

November 22nd 2020

AAO

During AAO 2020, Cathy G. Cohen, MHSA, CAE, AAO vice president for governmental affairs, offered some optimism for the future of health care under the Biden administration.

Virtual AAO Museum of the Eye event kicks off November 18

Virtual AAO Museum of the Eye event kicks off November 18

November 17th 2020

AAO

A unique Behind-the-Scenes series from the American Academy of Ophthalmology Truhlsen-Marmor Museum of the Eye kicks off November 18, from noon to 1 pm Pacific, with “The National Trachoma Service.” Register now for this event.

(AAO) Study outlines use of injectable intraocular steroid over drops

(AAO) Study outlines use of injectable intraocular steroid over drops

November 16th 2020

AAO

Robert Weinstock, MD, presents data from a retrospective multicenter study focusing on the efficacy of dexamethasone intraocular suspension 9% delivered at the time of cataract surgery.

AAO live: Fingolimod for MS offers disease control with no development of uveitis

AAO live: Fingolimod for MS offers disease control with no development of uveitis

November 15th 2020

AAO

Bradley Smith, MD, presents at AAO 2020 on how fingolimod 0.5 mg, a first-line treatment for multiple sclerosis, may reduce both the number of relapses and disease progression in patients with relapsing-remitting MS as well as the incidence of uveitis.

AAO live: Drop-free prophylaxis regimen before cataract surgery lowers treatment burden with caveats

AAO live: Drop-free prophylaxis regimen before cataract surgery lowers treatment burden with caveats

November 15th 2020

AAO

Speaking during the American Academy of Ophthalmology’s virtual 2020 annual meeting, Neal H. Shorstein, MD, explained how physicians at Kaiser Permanente have been using a prophylactic drop-free drug regimen before cataract surgery for more than a decade. Their regimen is so streamlined that the only drop that patients receive in anticipation of cataract surgery is a supplemental dilation drop instilled preoperatively while they are still in the holding area.

(AAO) Preventing cystoid macular oedema after cataract surgery

(AAO) Preventing cystoid macular oedema after cataract surgery

November 15th 2020

AAO

Rudy Nuijts of the University Eye Clinic Maastricht, the Netherlands, discusses the highlights of his AAO 2020 presentation on a combination treatment regimen for lowering the incidence of cystoid macular oedema following category surgery.

(AAO) Medication could reduce burden of steroid drops for patients

(AAO) Medication could reduce burden of steroid drops for patients

November 15th 2020

AAO

Cynthia Matossian, MD, FACS, ABES presents the highlights of a poster on outcomes with dexamethasone intraocular suspension 9% and concomitant postoperative anti-inflammatory medications.

(AAO) Alcon showcases advanced IOL technology for presbyopia

(AAO) Alcon showcases advanced IOL technology for presbyopia

November 15th 2020

AAO

Kristen Brotherson, vice president, US surgical marketing for Alcon, discusses some of the recent advances in cataract surgery-related technologies, including a new advanced lens for patients with presbyopia (AcrySof IQ Vivity IOL).

AAO live: Autologous retinal transplant for larger macular holes gaining traction

AAO live: Autologous retinal transplant for larger macular holes gaining traction

November 14th 2020

AAO

Tamer Mahmoud, MD, PhD, discusses autologous retinal transplant (ART) for macular holes, a procedure he developed, which is providing anatomic hole closure in the vast majority of cases as well as increases in visual acuity.

AAO live: Myopia progression slowed with orthokeratology, multifocal lenses

AAO live: Myopia progression slowed with orthokeratology, multifocal lenses

November 14th 2020

AAO

In a presentation at the American Academy of Ophthalmology’s virtual 2020 annual meeting, Amy K. Hutchinson, MD, explained that while Myopia has been occurring at epidemic rates worldwide, research has found that the use of orthokeratology and multifocal contact lenses can provide clinically meaningful reductions in myopia progression.